Observational Study of Transcatheter Aortic Valve Replacement for Bicuspid Aortic Valve Stenosis
This study is looking at people with severe bicuspid aortic valve stenosis (a heart condition where the aortic valve has two flaps instead of the usual three, and it's narrowed) who are undergoing transcatheter aortic valve replacement (TAVR). TAVR is a procedure to replace the aortic valve without open-heart surgery. The study aims to understand the results of this procedure in these patients. You might be able to join if you are 18 or older, have severe bicuspid aortic valve stenosis, and your heart team has decided TAVR is right for you. The main goal is to see how many people pass away at 1 month, 1 year, and 2 years after the procedure. The current recruitment status is unclear.
- Study design
- This is an observational study, meaning researchers will watch and collect information from 2000 participants. It is not a randomized study.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for outcomes like death at 1 month, 1 year, and 2 years after the procedure.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Bicuspid Aortic Valve Stenosis Transcatheter Aortic Valve Replacement Registry
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Death1 month
Death from any cause
- Death1 year
Death from any cause
- Death2 years
Death from any cause
- Death3 years
Death from any cause
- Death4 years
Death from any cause
- Death5 years
Death from any cause